Skip to main navigation
Skip to search
Skip to main content
Sort by
Neuroscience
3 Hydroxy 3 Methylglutaryl Coenzyme A
5%
Alzheimer's Disease
21%
Amyloid Protein
13%
Amyotrophic Lateral Sclerosis
33%
Aquaporin 4 Antibody
7%
Astrocyte
18%
Auras
9%
Autoantibodies
29%
Axon
5%
Behavior (Neuroscience)
6%
Biological Marker
8%
Blood Plasma
10%
Brain Ischemia
46%
Calcitonin Gene Related Peptide
10%
Calcitonin Gene-Related Peptide
7%
Cell Death
5%
Cell Signaling
6%
Central Nervous System
7%
Cerebral Hemorrhage
8%
Cerebrovascular Accident
14%
Cerebrovascular Disease
9%
Cyclic Adenosine Monophosphate
9%
Cyclic AMP Responsive Element Binding Protein
9%
Dopamine
7%
Eculizumab
12%
Encephalitis
7%
Endoplasmic Reticulum
12%
Endoplasmic Reticulum Stress
9%
Enzymes
11%
Fc Receptor
5%
Fluorine-18
7%
Glucose
11%
Headache
19%
Hippocampus
5%
Immune Checkpoint Inhibitor
7%
Immunohistochemistry
5%
Immunoprecipitation
5%
In Vivo
17%
Interleukin 6
13%
Ischemia
19%
L-DOPA
5%
Magnetic Resonance Imaging
16%
Messenger RNA
6%
Metabolic Pathway
8%
Microdialysis
5%
Microglia
16%
Microvessel
5%
Middle Cerebral Artery
16%
Migraine
39%
Monoclonal Antibody
9%
Motor Neuron
5%
Motor Neuron Disease
8%
Multiple Sclerosis
31%
Muscle Disorder
38%
Myasthenia gravis
65%
Myelin
10%
Myelinogenesis
8%
Myositis
16%
Nervous System Disorder
9%
Neurodegeneration
9%
Neurodegenerative Disorder
9%
Neuromyelitis Optica
11%
Nitric Oxide
12%
Non-Motor Symptoms
8%
Nuclear Transport
5%
Nucleus
7%
Oligodendrocyte
22%
Oligodendrocyte Progenitor
6%
Optogenetics
7%
Parkinson's Disease
33%
Pentose Phosphate
8%
phosphorylation
11%
Positron Emission Tomography
8%
Prednisolone
6%
Progenitor Cell
7%
Protein Binding
5%
Protein Phosphorylation
10%
Quality of Life
9%
Ravulizumab
5%
Reactive Oxygen Species
7%
Receptor
7%
Remyelinization
8%
Response Element
5%
RNA-binding Protein
11%
Serotonin
7%
Signal Recognition Particle
13%
Single-Photon Emission Computed Tomography
9%
Spinal Cord
5%
Spreading Cortical Depression
18%
Stem Cell
12%
Steroid
6%
Striatum
11%
T Cell
5%
TAR DNA Binding Protein
10%
Transcription Factor Nrf2
6%
Trigeminal Ganglion
7%
Keyphrases
3-hydroxy-3-methylglutaryl-coenzyme A
10%
95% Confidence Interval
10%
Acetylcholine Receptor Antibody
10%
Acute Phase
6%
Adverse Events
7%
Age of Onset
6%
Allogeneic Hematopoietic Stem Cell Transplantation (allo-HSCT)
6%
Alzheime's Disease
11%
Alzheimer's Disease
11%
Amyotrophic Lateral Sclerosis
26%
Anti-signal Recognition Particle Antibody
14%
Anti-SRP Myopathy
6%
Antisynthetase Syndrome
7%
Aquaporin-4 (AQP4)
5%
Autoantibodies
21%
Calcitonin Gene-related Peptide Monoclonal Antibody
10%
CAMP Response Element-binding Protein
9%
Central Nervous System
5%
Cerebral Ischemia
10%
Cerebrospinal Fluid
8%
Cerebrovascular Disease
5%
Clinical Characteristics
10%
Clinical Features
14%
Clinical Trials
11%
Cortical Spreading Depression
11%
Demyelination
10%
Eculizumab
15%
Endoplasmic Reticulum
6%
Endoplasmic Reticulum Stress (ER stress)
6%
Focal Cerebral Ischemia
6%
Fused in Sarcoma
5%
Headache
23%
Healthy Controls
7%
Immune Checkpoint Inhibitors
8%
Induced Pluripotent Stem Cells (iPSCs)
15%
Inflammatory Myopathy
27%
Interim Analysis
9%
Interleukin-6
8%
Intracerebral Hemorrhage
6%
Ischemia
8%
Ischemic Cerebrovascular Disease
11%
Ischemic Stroke
11%
Japan
59%
Japanese Patients
20%
Japanese Population
11%
Japanese Version
6%
Kv1.4
6%
Limbic Encephalitis
6%
Long-term Efficacy
6%
Microglia
8%
Middle Cerebral Artery
5%
Migraine
27%
Minimal Manifestations
8%
Motor Neuron
6%
Multiple Sclerosis
16%
Multiple Sclerosis Treatment
8%
Muscle Biopsy
6%
Muscle Pathology
6%
Muscle Weakness
5%
Muscular Dystrophy
6%
Myasthenia Gravis
100%
Myasthenic
5%
Myelination
5%
Myocarditis
7%
Myopathy
20%
Myositis
20%
Necrotizing Myopathy
11%
Neurodegeneration
6%
Neurological Diseases
11%
Neurology
8%
Neuromyelitis Optica Spectrum Disorder (NMOSD)
23%
Nitric Oxide Production
6%
Oligodendrocyte
6%
Oligodendrocyte Precursor Cells
11%
Parkinson Patients
7%
Parkinson's Disease
24%
Patients with Parkinson's Disease
6%
Phosphorylation
12%
Placebo
5%
Placebo-controlled
6%
Polymorphism
10%
Post-marketing Surveillance
9%
Prednisolone
7%
Quality of Life
5%
Randomized Double-blind
6%
Rat Brain
6%
Ravulizumab
7%
Recirculation
8%
Reductase
14%
Reperfusion
5%
RNA Immunoprecipitation
5%
RNA-binding Protein
8%
Satralizumab
10%
Seipin
9%
Spreading Depolarization
11%
Stem Cell-derived
6%
Temporal Profile
5%
Therapeutic Strategies
5%
Thymoma
13%
Treatment Strategy
6%
Medicine and Dentistry
Adverse Event
7%
Alzheimer's Disease
13%
Amino Acid Transfer RNA Ligase
5%
Amyloid Protein
11%
Anti N Methyl D Aspartate Receptor Encephalitis
5%
Antisynthetase Syndrome
6%
Apoplexy
10%
Autoantibodies
18%
Brain Disease
5%
Brain Infarction
5%
Brain Ischemia
6%
Calcitonin Gene Related Peptide
9%
Capillary
6%
Central Nervous System
6%
Cerebral Hemorrhage
14%
Clinical Feature
7%
Clinical Trial
5%
Cohort Analysis
7%
COVID-19
6%
Cross Sectional Study
10%
Dermatomyositis
6%
Diseases
22%
Dopamine Transporter
5%
Drug Megadose
5%
Eculizumab
6%
Glucocorticoid
5%
Headache
24%
HMG-CoA
7%
Immune Checkpoint Inhibitor
8%
Immunoprecipitation
6%
Infection
5%
Interim Analysis
7%
Iodine 123
7%
Levodopa
6%
Magnetic Resonance Imaging
10%
Mechanical Thrombectomy
5%
Methylprednisolone
6%
Migraine
37%
Monoclonal Antibody
10%
Multiple Chronic Conditions
7%
Multiple Sclerosis
22%
Muscle Biopsy
5%
Muscle Disease
6%
Muscle Weakness
6%
Myasthenia gravis
70%
Myelin
8%
Myopathy
38%
Myositis
28%
Neoplasm
6%
Neurologic Disease
9%
Neurology
5%
Neuromyelitis Optica
7%
Nivolumab
8%
Observational Study
10%
Onset Age
5%
Oral
16%
Oxidoreductase
10%
Parkinson's Disease
22%
Parkinsonism
6%
Pathogenesis
5%
Pathophysiology
5%
Phosphotransferase
5%
Placebo
6%
Positron Emission Tomography
5%
Prednisolone
15%
Prevalence
6%
Primary Headache
9%
Ptosis (Eyelid)
7%
Quality of Life
16%
Remyelination
9%
Satralizumab
5%
Signal Recognition Particle
11%
Single-Photon Emission Computed Tomography
9%
Skeletal Muscle
5%
Steroids
9%
Subgroup Analysis
6%
Surgery
6%
Systemic Lupus Erythematosus
5%
Tau
7%
Thymectomy
6%
Thymus Cancer
7%